Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,341 VRDN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Jul 2, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 21,000 | n/a |
| Jun 28, 2024 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 21,000 | n/a |
| Jun 16, 2023 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 20,000 | n/a |
| Jun 10, 2022 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 12,500 | n/a |
| Jul 15, 2021 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 25,000 | n/a |